MedPath

LINCO ACTIN INJECTION

Registration Number: MAL24066150HA

Approved
Approval ID

43dd8ef62c1c5323

Registration Number

MAL24066150HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types4 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (4)

20 mlAvailable
Package Size: 20 ml
Status: NPRA Approved
50 mlAvailable
Package Size: 50 ml
Status: NPRA Approved
100 mlAvailable
Package Size: 100 ml
Status: NPRA Approved
250 mlAvailable
Package Size: 250 ml
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

Lincomycin HydrochlorideActive
Monograph: 林可霉素
SPECTINOMYCIN SULFATEActive
Monograph: spectinomycin sulfate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LINCO ACTIN INJECTION - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform